NCT03274206 - A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions

Cervical Intraepithelial Neoplasia Grade 2/3

Interventions

BIOLOGICAL

BLS-ILB-E710c

BLS-ILB-E710c 250mg/capsule

DRUG

Placebo

BLS-ILB-E710c-placebo

Trial Locations (14)

11765

RECRUITING

Catholic University of Korea, Uijeongbu St. Mary's Hospital, Uijeongbu-si

13496

RECRUITING

CHA Bundang Medical Center, CHA University, Seongnam-si

15355

RECRUITING

Korea University Ansan Hospital, Ansan

16247

RECRUITING

Catholic University of Korea, St. Vincent's Hospital, Suwon

21565

RECRUITING

Gachon University Gil Medical Center, Incheon

700-712

RECRUITING

The Dongsan Medical Center of Keimyung Hospital, Daegu

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Yonsei Unversity Health System, Seoul

05505

RECRUITING

University of Ulsan College of Medicine, Asan Medical Center, Seoul

06591

RECRUITING

Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

07441

RECRUITING

Hallym University Medical Center, Seoul

100-380

RECRUITING

Kwandong University College of Medicine Cheil Hospital, Seoul

135-913

RECRUITING

CHA Gangnam Hospital, Seoul

152-703

RECRUITING

Korea University Guro Hospital, Seoul